Eligibility Requirements
What changed on this page, and why it matters. This page previously stated a 400% federal-poverty-level income limit. That figure is correct for most of the Novo Nordisk Patient Assistance Program but not for Ozempic, which is capped at 200%. It also described the programme as covering uninsured patients while offering a savings card to the commercially insured, which omitted the Medicare position entirely. Corrected 23 August 2026 against Novo Nordisk's own published criteria.
Confirm before you apply. Programme rules here changed recently and can change again. Novo Nordisk publishes current criteria and the application form at NovoCare. Nothing on this page is medical advice or a guarantee of eligibility; the determination is made by Novo Nordisk, not by us.
Covered Medications
The following medications are covered by Ozempic Savings (via NovoCare):
How to Apply
- Speak with your healthcare provider about Ozempic Savings (via NovoCare). Your doctor, nurse, or social worker can help determine if you qualify.
- Gather required documents: proof of income (tax return, pay stubs, or Social Security statement), valid prescription, and proof of U.S. residency.
- Submit your application online or by mail. Visit the program website below or call the program hotline for assistance.
- Wait for approval (typically 2 to 6 weeks). Once approved, medications will be shipped to your provider's office or a designated pharmacy.
Check If You Qualify
Use our free Assistance Finder tool to check eligibility for Ozempic Savings (via NovoCare) and other programs that may help reduce your medication costs.
Open Assistance FinderSources and standards behind this page
Drug coverage in the United States is governed by published rules rather than by any one insurer's summary, and the sources below are the primary ones. They are linked so a reader can check a claim without taking this page's word for it.
- FDA Orange Book publishes the therapeutic-equivalence ratings that decide whether a generic may be substituted for a brand-name drug.
- FDA generic drug facts sets out what "generic equivalent" means and what a manufacturer must prove.
- CMS prescription drug coverage defines the rules a Medicare drug plan formulary must follow and how it may change mid-year.
- Medicare.gov drug coverage (Part D) states what a Part D plan is required to offer a member.
- CMS prescription drug appeals documents the coverage-determination and exception process when a drug is denied.
- Medicare Plan Compare is the official tool for checking what a specific plan charges for a specific drug at a specific pharmacy.
- Drugs@FDA is the federal database of approved drug products, which establishes whether a covered product exists and in what form.
- DailyMed carries the current FDA labeling for every marketed drug product, including approved strengths and forms.
- MedlinePlus drug information is the National Library of Medicine's consumer reference for what a medication is and how it is used.
- FTC report on pharmacy benefit managers documents how the middlemen between an insurer and a pharmacy shape what a plan actually covers.
- National Library of Medicine maintains the drug and health databases the sources above draw on.
This page describes how coverage and formularies work. It is not medical advice, and a reader's own plan documents and prescriber decide what applies to them.
Frequently Asked Questions
Uninsured patients with income at or below 200% of the Federal Poverty Level can apply for free Ozempic. Ozempic is capped lower than the rest of the Novo Nordisk PAP, which applies 400% to its other products, and Medicare beneficiaries with prescription drug coverage are no longer eligible for Ozempic through the programme through the Novo Nordisk Patient Assistance Program at novocare.com. You will need a prescription and income verification.
Yes, commercially insured patients can use the Ozempic savings card to pay as little as $25 per 1-month, 2-month, or 3-month prescription fill. The card is not valid for patients with government insurance (Medicare, Medicaid, Tricare).
The Novo Nordisk PAP covers Ozempic when prescribed for type 2 diabetes. For weight management, Wegovy (also semaglutide) is the FDA-approved option, and it has its own patient assistance program through NovoCare.
Related Resources
- Compare pharmacy prices for Ozempic on RxGrab
- Ozempic supplement guide on Health Britannica
- Check drug interactions for Ozempic on OmniRx
- Browse all patient assistance programs
Get Prescription Savings Alerts
Subscribe to receive updates on patient assistance programs, drug price changes, and new savings opportunities.